Zhou, Wen-Yong
Shen, Lei
Shi, Jian-Xin
Gao, Xing-Hui
Yang, Jun
Fu, Shi-Jie
Pan, Xu-Feng
Zhu, Min-Fang
Zhang, Shen
Zhang, Chong
Li, Feng
Zhang, Hai
Yao, Feng
Tenover, Fred C.
Tang, Yi-Wei
Fang, Wen-Tao
Funding for this research was provided by:
National Natural Science Foundation of China (82170108)
Basic Research Foundation of Shanghai Chest Hospital (2020YNJCM05)
Foundation of the Center for Medical and Engineering Interdisciplinary Innovation, University of Shanghai for Science and Technology
Clinical Research Projects in Health industry of Shanghai Municipal Health Commission
Cepheid Investigator-Initiated Study award (Cepheid-IIS-2020-0019, Cepheid-IIS-2020-0019, Cepheid-IIS-2020-0019)
Interdisciplinary Program of Shanghai Jiao Tong University (YG2019QNA51)
Article History
Received: 3 May 2023
Accepted: 22 August 2023
First Online: 31 August 2023
Declarations
:
: X.G., F.C.T., and Y.W.T. are employees of Cepheid, the commercial manufacturer of the Xpert® Carba-R test. The other authors declare no competing interests.
: This historically controlled prospective trial was approved by the Ethics Committee of Shanghai Chest Hospital, Shanghai Jiao Tong University (No. IS21101) and registered on chictr.org.cn (ChiCTR2100053687). The study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.